Home > News > CytImmune teams with UMBI on nanotech product
April 28th, 2008
CytImmune teams with UMBI on nanotech product
CytImmune Sciences, which is developing a nanotech treatment for cancer, will become the first industry ‘‘customer" to use the biomanufacturing facility at the University of Maryland Biotechnology Institute.
The Rockville facility was built in 2006 specifically to help small companies meet federal quality standards for their products.
CytImmune, with 16 employees, will partner with UMBI's ‘‘good manufacturing practices" facility to help develop AuriTol, which uses nanotechnology to target cancer, said Lawrence Tamarkin, CEO of the Rockville company.
AuriTol is the second drug that CytImmune is developing. The first, Aurimune, will soon enter phase 2 human clinical trials.
News and information
Squeezing light into metals: University of Utah engineers control conductivity with inkjet printer March 7th, 2014
Up-Converted Radio: The way to treat radio waves in a noisy environment is to turn them into visible light March 7th, 2014
Colored diamonds are a superconductor’s best friend March 6th, 2014
Take Your Best Shot! JEOL Launches SEM/TEM Image Contest March 6th, 2014
SUNY CNSE Researchers to Present Nearly Two Dozen Technical Papers at Leading Lithography Conference: CNSE scientists to showcase industry-shaping research as part of SPIE Advanced Lithography 2014 forum February 21st, 2014
Northwestern University’s International Institute for Nanotechnology partners NTU to develop new healthcare technologies: S$70 million global research institute launched in the emerging field of nanomedicine February 21st, 2014
University institutes are shaping future of research: Cross-pollination between scientific disciplines is key to creative solutions February 15th, 2014
Shining a light on tiny polymer shapes: Visiting graduate student studies high-throughput manufacturing of precisely shaped microparticles February 11th, 2014
MANA Research Highlight: Smart nanofibers to treat kidney failure March 6th, 2014
Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc. March 6th, 2014
First Look at How Individual Staphylococcus Cells Adhere to Nanostructures Could Lead to New Ways to Thwart Infections: Berkeley Lab-led research could guide the development of bacteria-resistant materials March 5th, 2014
Dartmouth Researchers Find Promising Results with Local Hyperthermia of Tumors March 4th, 2014
Optimum Stable Conditions Achieved for Growth of Semiconducting Nanostructures on Metals March 5th, 2014
UC research tests which nano system works best in killing cancer cells: New UC research to be presented this week tested four iron-oxide nanoparticle systems to see which, when heated, would likely work best as a tool for targeting cancer cells March 4th, 2014
‘Four!' Heads Up, Wide Use of More Flexible Metallic Glass Coming Your Way: Advances in Glass Alloys Lead to Strength, Flexibility March 4th, 2014
The Universitat Politècnica de Valencia coordinates a European project that will improve data communications performance March 3rd, 2014